Since alterations in splicing mechanisms are frequent in cancer cells [77,78] it will be important to determine whether such mechanisms could alter FAK properties, either by modulating the mRNA levels, or by changing the coding sequence of expressed proteins. Here, PTK2 is linked to cancer.